Sequence of horse (Equus caballus) apoA-II. Another example of a dimer forming apolipoprotein

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 138, Issue 3, 2004, Pages 213-220

  Puppione, Donald L ^a   Fischer, Wolfgang H ^b   Park, Minkyu ^b   Whitelegge, Julian P ^a   Schumaker, Verne N ^a   Golfeiz, Shoulamit ^a   MacDonald, Melinda H ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti microbial; Heterodimer; Methionine sulfoxide; Senescence; Thyroid binding proteins

Indexed keywords

APOLIPOPROTEIN A2; CYSTEINE; DIMER; ENZYME; PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HORSE; MALE; MAMMAL; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EQUUS; EQUUS CABALLUS; MAMMALIA; PAN TROGLODYTES; PRIMATES;

EID: 3142534419     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2004.02.008     Document Type: Article

References (62)

1. Babin P.J. Binding of thyroxine and 3, 5, 3′-triiodothyronine to trout plasma lipoproteins. Am. J. Physiol. 262:1992;E712-E720
2. Barker W.C., Dayhoff M.O. Evolution of lipoproteins deduced from protein sequence data. Comp. Biochem. Physiol. B. 57:1977;309-315
3. Benvenga S., Cahnmann H.J., Rader D., Kindt M., Robbins J. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3. Endocrinology. 131:1992;2805-2811
4. Benvenga S., Cahnmann H.J., Rader D., Kindt M., Facchiano A., Robbins J. Thyroid hormone binding to isolated human apolipoproteins A-II, C-I, C-II, and C-III: homology in thyroxine binding sites. Thyroid. 4:1994;261-267
5. Benvenga S. A thyroid hormone binding motif is evolutionarily conserved in apolipoproteins. Thyroid. 7:1997;605-611
6. Bernini F., Calabresi L., Bonfadini G., Franceschini G. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux. Biochim. Biophys. Acta. 1299:1996;103-109
7. Bielicki J.K., Oda M.N. Apolipoprotein A-I (Milano) and apolipoprotein A-I (Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry. 41:2002;2089-2096
8. Blanco-Vaca F., Via D.P., Yang C.Y., Massey J.B., Pownall H.J. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins. J. Lipid Res. 33:1992;1785-1796
9. Blaton V., Vercaemst R., Vandecasteele N., Caster H., Peeters H. Isolation and partial characterization of chimpanzee plasma high density lipoproteins and their apolipoproteins. Biochemistry. 13:1974;1127-1135
10. Blaton V., Vercaemst R., Rosseneu M., Mortelmans J., Jackson R.L., Gotto A.M. Jr, et al. Characterization of baboon plasma high-density lipoproteins and of their major apoproteins. Biochemistry. 16:1977;2157-2163
11. Brewer H.B., Lux S.E., Ronan R., John K.M. Amino acid sequence of human apoLp-GlnII (apoA-II), an apolipoprotein isolated from the high density lipoprotein. Proc. Natl. Acad. Sci. USA. 69:1972;1304-1308
12. Castellani L.W., Navab M., van Lenten B.J., Hedrick C.C., Hama S.Y., Goto A.M., et al. Overexpression of apolipoprotein A-II in transgenic mice converts high density lipoproteins to proinflammatory particles. J. Clin. Invest. 100:1997;464-474
13. Chapman M.J. Animal lipoproteins: chemistry, structure, and comparative aspects. J. Lipid Res. 21:1980;789-853
14. Clark S.B., Tercyak A.M., Glander K.E. Plasma lipoproteins of free-ranging howling monkeys (Alouatta palliata). Comp. Biochem. Physiol. B. 88:1987;729-735
15. Collet X., Marcel Y.L., Tremblay N., Lazure C., Milne R.W., Perret B., et al. Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: correlation with primary and secondary structure. J. Lipid Res. 38:1997;634-644
16. Crook D., Weisgraber K.H., Rall S.C. Jr, Mahley R.W. Isolation and characterization of several plasma apolipoproteins of common marmoset monkey. Arteriosclerosis. 10:1990;625-632
17. Doolittle M.H., LeBoeuf R.C., Warden C.H., Bee L.M., Lusis A.J. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition. J. Biol. Chem. 265:1990;16 380-16 388
18. Edelstein C., Lim C.T., Scanu A.M. On the subunit structure of the protein of human serum high density lipoprotein. I. A study of its major polypeptide component (Sephadex, fraction 3). J. Biol. Chem. 247:1972;5842-5849
19. Edelstein C., Noyes C., Keim P., Heinrikson R.L., Fellows R.E., Scanu A.M. Covalent structure of apolipoprotein A-II from Macaca mulatta serum high-density lipoproteins. Biochemistry. 15:1976;1262-1268
20. Edelstein C., Lewis L.L., Shainoff J.R., Naito H., Scanu A.M. Isolation and characterization of a dog serum lipoprotein having apolipoprotein A-I as its predominant protein constituent. Biochemistry. 15:1976;1934-1941
21. Gong E.L., Stoltzfus L.J., Brion C.M., Murugesh D., Rubin E.M. Contrasting in vivo effects of murine and human apolipoprotein A-II. J. Biol. Chem. 271:1996;5984-5987
22. Hedrick C.C., Castellani L.W., Warden C.H., Puppione D.L., Lusis A.J. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268:1993;20 676-20 682
23. Herbert P.N., Windmueller H.G., Bersot T.P., Shulman R.S. Characterization of the rat apolipoproteins. I. The low molecular weight proteins of rat plasma high density lipoproteins. J. Biol. Chem. 249:1974;5718-5724
24. Herbert P.N., Bausserman L.L., Lynch K.M., Saritelli A.L., Kantor M.A., Nicolosi R.J., et al. Homologues of the human C and A apolipoproteins in the Macaca fascicularis (cynomolgus) monkey. Biochemistry. 10:1987;1457-1463
25. Higuchi K., Yonezu T., Kogishi K., Matsumura A., Takeshita S., Higuchi K., et al. Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J. Biol.Chem. 261:1986;12 834-12 840
26. Higuchi K., Kitagawa K., Naiki H., Hanada K., Hosokawa M., Takeda T. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem. J. 279:1991;427-433
27. Hollanders B, Mougin A., N'Diaye F., Hentz E., Aude X., Girard A. Comparison of the lipoprotein profiles obtained from rat, bovine, horse, dog, rabbit and pig serum by a new two-step ultracentrifugal gradient procedure. Comp. Biochem. Physiol. B. 84:1986;83-89
28. Ishida B.Y., Blanche P.J., Nichols A.V., Yashar M., Paigen B. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. J. Lipid Res. 32:1991;559-568
29. Jackson R.L., Baker H.N., Taunton O.D., Smith L.C., Garner C.W., Gotto A.M. Jr. A comparison of the major apolipoprotein from pig and human high density lipoproteins. J. Biol. Chem. 248:1973;2639-2644
30. Kalopissis A.-D., Pastier D., Chambaz J. Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance. Curr. Opin. Lipidol. 14:2003;165-172
31. Kostner G., Alaupovic P. Studies of the composition and structure of plasma lipoproteins. C- and N-terminal amino acids of the two non-identical polypeptides of human plasma apolipoprotein A. FEBS Lett. 15:1971;320-324
32. Kumar M.S., Carson M., Hussain M.M., Murthy H.M.K. Structures of apolipoprotein A-II and a lipid-surrogate complex provide insights into apolipoprotein-lipid interactions. Biochemistry. 41:2002;11 681-11 691
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
34. Le Goff D., Pastier D., Hannan Y., Petit E., Ayrault-Jarrier M., Nouvelot A. Lipid and apolipoprotein distribution as a function of density in equine plasma lipoprotein. Comp. Biochem. Physiol. B. 93:1989;371-377
35. Li W-H, Tanimura M., Luo C-C, Datta S., Chan L. The apolipoprotein multigene family: biosynthesis, structure-function relationship, and evolution. J. Lipid Res. 29:1988;245-271
36. Lindgren F.T. Preparative ultracentrifugal laboratory procedures and suggestion for lipoprotein analysis. Perkins E.G. Analysis of Lipids and Lipoproteins. 1975;204-224 American Oil Chemists Society, Champaign, IL
37. Lund-Katz S., Murley Y.M., Yon E., Gillotte K.L., Davidson W.S. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles. Lipids. 31:1996;1107-1113
38. Machebeuf M. Recherches sur les phosphoaminolipides et les sterides du serum et du plasma sanguins. 1. Entrainement des phospholipides, des sterols at des sterides par les diverses fractions au cours du fragtionnement des proteides du serum. Bull. Chim. Biol. 11:1929;268-293
39. Mahley R.W., Weisgraber K.H., Innerarity T., Brewer H.B. Jr. Characterization of the plasma lipoproteins and apoproteins of the Erythrocebus patas monkey. Biochemistry. 15:1976;1928-1933
40. Miller C.G., Lee T.D., LeBoeuf R.C., Shively J.E. Primary structure of apolipoprotein A-II from inbred mouse strain BALB/c. J. Lipid Res. 28:1987;311-319
41. Motizuki M., Itoh T., Yamada M., Shimamura S., Tsurugi K. Purification, primary structure, and antimicrobial activities of bovine apolipoprotein A-II. J. Biochem. 123:1998;675-679
42. Motizuki M., Itoh T., Satoh T., Yokota S., Yamada M., Shimamura S., et al. Lipid-binding and antimicrobial properties of synthetic peptides of bovine apolipoprotein A-II. Biochem. J. 342:1999;215-221
43. Motizuki M., Satoh T., Takei T., Itoh T., Yokota S., Kojima S., et al. Structure-activity analysis of an antimicrobial peptide derived from bovine apolipoprotein A-II. J. Biochem. (Tokyo). 132:2002;115-119
44. Nicolosi R.J., Hayes K.C. Lipoproteins of cebus monkeys. Lewis L.A., Naito H.K. Handbook of Electrophoresis. IV:1983;33-51 CRC Press, Boca Raton, FL
45. Pankhurst G., Wang X.L., Wilcken D.E., Baernthaler G., Panzenbock U., Raftery M., et al. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. J. Lipid Res. 44:2003;349-355
46. Parks J.S., Rudel L.L. Isolation and characterization of high density lipoprotein apoproteins in the non-human primate (vervet). J. Biol.Chem. 254:1979;6716-6723
47. Perez-Mendez O., Bruckert E., Fraceschini G., Duhal N., Lacroix B., Bonte J.P., et al. Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris. Atherosclerosis. 148:2000;317-325
48. Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chretien Y., et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J. 16:2002;185-194
49. Perrin M.H., Fischer W.H., Kunitake K.S., Craig A.G., Koerber S.C., Cervini L.A., et al. Expression, purification and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor. J. Biol. Chem. 276:2001;31 528-31 534
50. Puppione D.L., Fischer W.H., Park M., Gazal O.S., Williams G.L. Microsequencing of bovine cerebrospinal fluid apolipoproteins: identification of bovine apolipoprotein E. Lipids. 33:1998;781-786
51. Rudman D., Garcia F., Smith D. A new method for isolating the non-identical protein subunits of human plasma alpha-lipoproteins. J. Clin. Invest. 49:1970;365-372
52. Scanu A.M., Edelstein C., Lim C.T. Effect of disulfide cleavage on the molecular weight of one of the major polypeptides of human serum high density lipoprotein. FEBS Lett. 18:1971;305-307
53. Scanu A.M., Edelstein C., Wolf R.H. Chimpanzee (Pan troglodytes) serum high density lipoproteins. Isolation and properties of their two major apolipoproteins. Biochim. Biophys. Acta. 351:1974;341-347
54. Segrest J.P., Jones M.K., de Loof H., Brouillette C.G., Venkatachalapathi Y.V., Anantharamaiah G.N. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33:1992;141-166
55. Shore V., Shore B. Some physical and chemical studies on two polypeptide components of high-density lipoproteins of human serum. Biochemistry. 7:1968;3396-3403
56. Watson T.D., Burns L., Love S., Packard C.J., Shepherd J. The isolation, characterisation and quantification of the equine plasma lipoproteins. Equine Vet. J. 23:1991;353-359
57. Watson T.D., Packard C.J., Shepherd J. Plasma lipid transport in the horse (Equus caballus). Comp. Biochem. Physiol. B. 106:1993;27-34
58. Weber K., Osborne M. Proteins and sodium dodecyl sulfate: molecular weight determination on polyacrylamide gels and related procedures. Neurath H., Hill R.L. The Proteins. IV:1975;179-223 Academic Press, New York, NY
59. Weisgraber K.H., Mahley R.W. Apoprotein (E-A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J. Biol. Chem. 253:1978;6281-6288
60. Weisgraber, K.H., 1994. Apolipoprotein E: structure-function relationships. In: Schumaker, V.N. (Ed.), Adv. Protein Chem. vol. 45. Academic Press, New York, NY, pp. 249-302
61. Whitelegge J.P., Gundersen C., Faull K.F. Electrospray-ionization mass spectrometry of intact intrinsic membrane proteins. Protein Sci. 7:1998;1423-1430
62. Whitelegge J.P., le Coutre J., Lee J.C., Engel C.K., Privé G.G., Faull K.F., et al. Towards the bilayer proteome, electrospray-ionization mass spectrometry of large intact transmembrane proteins. Proc. Natl. Acad. Sci. USA. 96:1999;10 695-10 698